Free Trial

Everett Harris & Co. CA Has $959,000 Stake in Utah Medical Products, Inc. (NASDAQ:UTMD)

Utah Medical Products logo with Medical background

Key Points

  • Everett Harris & Co. CA significantly increased its stake in Utah Medical Products by 327.7%, now owning approximately 17,116 shares worth around $959,000.
  • The company recently announced a quarterly dividend of $0.305 per share, which will be paid on October 2nd, representing an annualized yield of 2.2%.
  • Utah Medical Products reported earnings of $0.94 per share and a revenue of $9.95 million for the last quarter, with a net margin of 32.34%.
  • Five stocks to consider instead of Utah Medical Products.

Everett Harris & Co. CA raised its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 327.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,116 shares of the medical instruments supplier's stock after purchasing an additional 13,114 shares during the quarter. Everett Harris & Co. CA owned about 0.52% of Utah Medical Products worth $959,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its stake in shares of Utah Medical Products by 172.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock valued at $32,000 after purchasing an additional 328 shares during the period. Wells Fargo & Company MN increased its stake in shares of Utah Medical Products by 24.9% during the fourth quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after acquiring an additional 384 shares during the period. Bessemer Group Inc. acquired a new position in shares of Utah Medical Products during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC increased its stake in shares of Utah Medical Products by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after acquiring an additional 500 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in shares of Utah Medical Products by 156.9% during the first quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock valued at $50,000 after acquiring an additional 546 shares during the period. Institutional investors and hedge funds own 69.60% of the company's stock.

Utah Medical Products Price Performance

Shares of NASDAQ UTMD traded up $1.39 during mid-day trading on Tuesday, reaching $57.64. 2,541 shares of the company traded hands, compared to its average volume of 18,099. Utah Medical Products, Inc. has a fifty-two week low of $51.26 and a fifty-two week high of $69.30. The firm has a market cap of $187.33 million, a PE ratio of 15.41 and a beta of 0.31. The stock has a fifty day simple moving average of $56.38 and a 200-day simple moving average of $56.45.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%. The business had revenue of $9.95 million for the quarter.

Utah Medical Products Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be paid a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's dividend payout ratio (DPR) is currently 32.62%.

Utah Medical Products Profile

(Free Report)

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Further Reading

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Should You Invest $1,000 in Utah Medical Products Right Now?

Before you consider Utah Medical Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.

While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines